Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,385,454
+$9,760,776 QoQ
Shares Held
767,525
-9.1% QoQ
Ownership
0.552%
of shares outstanding
% of Portfolio
6.64%
of 13F equity value
Holder Rank
#42
of 477 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2024CallValue
$56,095,011
CallShares
800,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Melqart Asset Management (UK) Ltd holds $144,610,610 across 5 Biotechnology names. CYTK ranks #1 (45.2% of the industry book) .
All Filings in CYTK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,385,454 | 767,525 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $55,624,678 | 843,949 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $39,578,938 | 622,898 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,076,219 | 783,774 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,834,795 | 1,326,719 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $40,167,774 | 999,447 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $53,457,855 | 1,136,434 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $64,007,222 | 1,212,258 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $90,794,031 | 1,675,785 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $68,945,823 | 983,395 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $56,095,011 | 800,100 | Call | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||